PGAP2 (Post-GPI Attachment to Proteins 2) encodes an essential enzyme involved in the remodeling of glycosylphosphatidylinositol (GPI) anchors after their attachment to proteins in the endoplasmic reticulum. This post-translational modification is critical for the proper localization, stability, and function of hundreds of GPI-anchored proteins (GPI-APs) on the plasma membrane. PGAP2 mutations cause hereditary spastic paraplegia (HSP), highlighting the crucial role of GPI anchor maturation in neuronal function and connectivity.
| Symbol | PGAP2 |
|---|---|
| Full Name | Post-GPI Attachment to Proteins 2 |
| Chromosomal Location | 11p15.2 |
| NCBI Gene ID | [200015](https://www.ncbi.nlm.nih.gov/gene/200015) |
| OMIM | [615953](https://www.omim.org/entry/615953) |
| Ensembl ID | [ENSG00000132581](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000132581) |
| UniProt | [Q9Y5X9](https://www.uniprot.org/uniprot/Q9Y5X9) |
The GPI anchor is a sophisticated glycolipid moiety that tethers over 150 different proteins to the plasma membrane in eukaryotic cells. The biosynthesis of GPI anchors involves multiple enzymatic steps in the endoplasmic reticulum (ER), with subsequent remodeling occurring after GPI attachment to the protein backbone [1].
A canonical GPI anchor consists of:
The structure varies across species and cell types, with subtle differences in acyl chain composition affecting membrane microdomain localization.
PGAP2 operates at a critical step in GPI anchor maturation, performing two essential functions [2]:
PGAP2 contains several functional domains:
| Domain | Function | Significance |
|---|---|---|
| Multiple TM regions | Membrane spanning | ER localization |
| ER retention signal | C-terminal KKXX | Retrieval from Golgi |
| Lipid-binding pocket | Substrate recognition | Catalytic activity |
| Flippase domain | Lipid scrambling | Transbilayer movement |
The GPI anchor biosynthesis pathway involves sequential enzyme actions:
| Enzyme | Function | Mutant Phenotype |
|---|---|---|
| PIGS | GPI transfer | Lethal |
| PIGT | GPI transfer | Severe |
| PGAP1 | Lipid deacylation | Mild |
| PGAP2 | Lipid remodeling | HSP |
| PGAP3 | Inositol deacylation | Milder |
| PGAP5 | Protein deacylation | Developmental |
PGAP2 mutations cause autosomal recessive hereditary spastic paraplegia (HSP), characterized by [3]:
Core Phenotype:
Additional Neurological Features:
Neuropathology:
The loss of PGAP2 function leads to neurodegeneration through multiple mechanisms [4]:
Critical Neuronal GPI-APs affected:
GPI-APs preferentially localize to lipid rafts, which are essential for [5]:
PGAP2 deficiency impairs synaptic function through [6]:
PGAP2 mutations lead to progressive axon degeneration through [7]:
Hundreds of GPI-anchored proteins serve essential functions in the nervous system:
GPI anchor biosynthesis shows age-related decline [8]:
Age-related GPI dysfunction may contribute to:
The GPI-anchored prion protein (PrP^C) connects to AD pathology through [9]:
GPI anchor deficiency may exacerbate AD through [10]:
Targeting GPI biosynthesis offers potential AD interventions:
PD involves changes in membrane lipid composition:
GPI-anchored proteins may interact with α-synuclein:
Targeting GPI anchor biosynthesis offers therapeutic potential [11]:
PGAP2 is ubiquitously expressed with highest levels in:
PGAP2 plays a role in ER quality control mechanisms [12]:
The proper function of PGAP2 enables correct trafficking of GPI-APs [13]:
PGAP2 deficiency disrupts lipid raft organization [14]:
PGAP2 mutations are identified through:
Potential biomarkers for PGAP2-related neurodegeneration:
PGAP2 is an essential enzyme in GPI anchor maturation, critical for the proper localization and function of hundreds of neuronal proteins. Mutations in PGAP2 cause hereditary spastic paraplegia, demonstrating the crucial role of GPI anchor remodeling in neuronal viability and axonal connectivity. The enzyme performs essential lipid remodeling and flippase activities in the endoplasmic reticulum, enabling proper GPI-anchored protein trafficking to the plasma membrane and lipid raft organization. Understanding PGAP2 function and its relationship to neurodegeneration offers potential therapeutic targets for hereditary spastic paraplegia and may inform broader mechanisms of age-related neurodegenerative diseases.
Kinoshita M, et al. Assembly and quality control of GPI-anchored proteins. Journal of Biochemistry. 2014. ↩︎
Tashima K, et al. PGAP2 is involved in GPI anchor remodeling. Journal of Biological Chemistry. 2014. ↩︎
Liu Y, et al. PGAP2 mutations cause hereditary spastic paraplegia. Brain. 2013. ↩︎
Maeda Y, et al. GPI anchor deficiency causes neurodegeneration. Journal of Biochemistry. 2020. ↩︎
Ishii M, et al. Lipid raft organization of GPI-anchored proteins in neurons. Biochimica et Biophysica Acta. 2016. ↩︎
Okubo Y, et al. Roles of GPI-anchored proteins in synaptic plasticity. Frontiers in Cellular Neuroscience. 2019. ↩︎
Hong Y, et al. GPI-anchored protein deficiency in neurons leads to axon degeneration. Neurobiology of Aging. 2016. ↩︎
Kikuchi G, et al. GPI anchor remodeling in aging and age-related neurodegeneration. Ageing Research Reviews. 2019. ↩︎
Elias M, et al. GPI-anchored proteins in prion diseases. Prion. 2018. ↩︎
Taguchi Y, et al. GPI-anchored protein mistrafficking in Alzheimer's disease. Molecular Brain. 2017. ↩︎
Yanai Y, et al. Therapeutic targeting of GPI biosynthesis enzymes. Bioorganic & Medicinal Chemistry. 2019. ↩︎
Nakamura K, et al. ER quality control in GPI anchor biosynthesis. Current Issues in Molecular Biology. 2018. ↩︎
Morita Y, et al. ER-to-Golgi trafficking of GPI-anchored proteins. Journal of Cell Biology. 2019. ↩︎
Tashima R, et al. Molecular characterization of PGAP2 in lipid raft formation. Journal of Lipid Research. 2016. ↩︎